Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus10 enrolled

Overview

Treatment of chronic medium-severe periodontitis with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction

The bone defect will be filled with a porous membrane based on bone collagen measuring 5x5 mm or more with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Periodontitis, Chronic

Interventions

mesenchymal stem cellsBIOLOGICAL

autologous mesenchymal stem cells

standard treatmentOTHER

standard treatment according to clinical protocols

Eligibility

Sex: ALLMin age: 70 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- chronic medium-severe periodontitis Exclusion Criteria: * pregnancy * breast-feeding * acute and chronic infectious diseases: HIV, viral hepatitis, tuberculosis * mental disorders

Locations (1)

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

Minsk, Belarus

Outcomes

Primary Outcomes

number of patients cured

Time frame: 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.